Data from the Living Tumor Lab platform revealed that some xenografts showed particularly high CACNA1H expression, but no correlation seems to exist between this parameter and clinical (e.g. stage) or pathological (e.g. histology) features. This evidence concerns the gene CACNA1H and neoplasm.